NYSE · Analyst Forecast

Edwards Lifesciences Corporation (EW) Stock Forecast & Price Target

$105.30 NYSE: EW Market Cap $60.55B

Price as of Nov 17, 2026 (intraday, delayed) · Analyst estimates retrieved Nov 14, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Edwards Lifesciences Corporation (EW), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Edwards Lifesciences Corporation, analysts forecast revenue rising from $6.04B in 2025 to $9.85B in 2030; the average estimate for 2030 earnings per share is $4.70; with published estimates ranging from $4.55 to $4.82; 25 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$105.30
Consensus targetThe average of the price targets analysts have published.$108.70
Median targetThe middle target, less affected by a single outlier.$110.00
Highest targetThe most optimistic published target.$120.00
Lowest targetThe most pessimistic published target.$100.00
Difference from priceHow far the consensus target sits from today’s price.+3.2%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$5.99B$6.04B$6.08B22
2026$6.73B$6.81B$6.84B21
2027$7.28B$7.49B$7.54B22
2028$7.91B$8.24B$8.66B25
2029$8.82B$9.04B$9.23B12
2030$9.61B$9.85B$10.05B12

Earnings per share forecast

YearLowAverageHighAnalysts
2025$2.58$2.60$2.6222
2026$3.01$3.02$3.0621
2027$3.31$3.40$3.4822
2028$3.29$3.84$4.1625
2029$4.12$4.25$4.3712
2030$4.55$4.70$4.8212

Edwards Lifesciences Corporation (EW) forecast — frequently asked questions

What is the analyst price target for Edwards Lifesciences Corporation?

Analysts covering Edwards Lifesciences Corporation (EW) have a consensus price target of $108.70, 3.2% above the current price of $105.30. Published targets range from $100.00 to $120.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Edwards Lifesciences Corporation's earnings?

The average analyst estimate for Edwards Lifesciences Corporation (EW) earnings per share in 2030 is 4.70, with individual estimates between 4.55 and 4.82.

How much revenue is Edwards Lifesciences Corporation expected to make?

Analysts forecast Edwards Lifesciences Corporation (EW) revenue of $9.85B in 2030, based on 12 published estimates.

How many analysts cover EW?

25 analysts contribute estimates for Edwards Lifesciences Corporation (EW). Thin coverage makes an average less reliable.

Analyst forecasts for other Medical - Devices stocks

ABT forecastISRG forecastMDT forecastSYK forecastBSX forecastRMD forecastDXCM forecastPHG forecastZBH forecastGKOS forecastAll Medical - Devices stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.